UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | R | S | T | U | V | W | Z
Number of items: 155.

A

Abou-Sleiman, PM; Healy, DG; Ahmadi, K; Goldstein, DB; Wood, NW; (2003) Population genetic approaches to Parkinsons disease. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 541 - 541). UNIV CHICAGO PRESS

Abou-Sleiman, PM; Healy, DG; Quinn, N; Lees, AJ; Wood, NW; (2003) The role of pathogenic DJ-1 mutations in Parkinson's disease. ANN NEUROL , 54 (3) 283 - 286. 10.1002/ana.10675.

Abramov, A.Y.; Canevari, L.; Duchen, M.R.; (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. Nature Chemical Biology , 23 (12) pp. 5088-5095. Green open access
file

Abramov, AY; Canevari, L; Duchen, MR; (2003) Amyloid beta peptide causes [Ca2+](c) fluctuations and decreases [GSH] in rat astrocytes. In: BIOPHYSICAL JOURNAL. (pp. 389A - 389A). BIOPHYSICAL SOCIETY

Abramov, AY; Canevari, L; Duchen, MR; (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J NEUROSCI , 23 (12) 5088 - 5095.

Abramov, AY; Duchen, MR; (2003) Actions of ionomycin, 4-BrA23187 and a novel electrogenic Ca2+ ionophore on mitochondria in intact cells. CELL CALCIUM , 33 (2) 101 - 112.

Ahmad-Annuar, A; Shah, P; Hafezparast, M; Hummerich, H; Witherden, AS; Morrison, KE; Shaw, PJ; (2003) No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. AMYOTROPH LATERAL SC , 4 (3) 150 - 157.

Alves, JD; Ames, PRJ; Donohue, S; Stanyer, L; Nourooz-Zadeh, J; Ravirajan, C; Isenberg, DA; (2003) Antibodies to high-density lipoprotein and beta(2)-glycoprotein I are inversely correlated with paraoxonase activity in systematic lupus erythematosus (vol 46, pg 2686, 2002). ARTHRITIS RHEUM , 48 (1) 284 - 284. 10.1002/art.539.

Andorfer, C; Kress, Y; Espinoza, M; de Silva, R; Tucker, KL; Barde, YA; Duff, K; (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J NEUROCHEM , 86 (3) 582 - 590. 10.1046/j.1471-4159.2003.01879.x.

B

Baptista, MJ; O'Farrell, C; Daya, S; Ahmad, R; Miller, DW; Hardy, J; Farrer, MJ; (2003) Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem , 85 (4) pp. 957-968.

Baptista, MJ; O'Farrell, C; Hardy, J; Cookson, MR; (2003) Microarray analysis reveals induction of heat shock proteins mRNAs by the torsion dystonia protein, TorsinA. Neurosci Lett , 343 (1) pp. 5-8.

Baumann, M; Mamais, A; McBlane, F; Xiao, H; Boyes, J; (2003) Regulation of V(D)J recombination by nucleosome positioning at recombination signal sequences. EMBO J , 22 (19) 5197 - 5207.

Boreström, C; Zetterberg, H; Liff, K; Rymo, L; (2003) Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter. J Virol , 77 (2) pp. 821-829.

Brancati, F; Valente, EM; Davies, NP; Sarkozy, A; Sweeney, MG; LoMonaco, M; Pizzuti, A; (2003) Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J NEUROL NEUROSUR PS , 74 (9) 1339 - 1341.

C

Cairns, NJ; Perry, RH; Jaros, E; Burn, D; McKeith, IG; Lowe, JS; Holton, J; (2003) Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. NEUROSCI LETT , 341 (3) 177 - 180. 10.1016/S0304-3940(03)00100-9.

Church, AJ; Dale, RC; Cardoso, F; Candler, PM; Chapman, MD; Allen, ML; Klein, NJ; (2003) CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome? J NEUROIMMUNOL , 136 (1-2) 149 - 153. 10.1016/S0165-5728(03)00012-2.

Church, AJ; Dale, RC; Lees, AJ; Giovannoni, G; Robertson, MM; (2003) Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J NEUROL NEUROSUR PS , 74 (5) 602 - 607.

Colosimo, C; Hughes, AJ; Kilford, L; Lees, AJ; (2003) Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J NEUROL NEUROSUR PS , 74 (7) 852 - 856.

Colosimo, C; Osaki, Y; Vanacore, N; Lees, AJ; (2003) Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study. Mov Disord , 18 (6) pp. 694-697. 10.1002/mds.10392.

Cordivari, C; Vincent, A; Misra, VP; Catania, S; Murray, NMF; Bhatia, KP; Lees, AJ; (2003) Failure to identify change in the cervical dystonia muscle pattern is the main cause of reduced response to BTXA. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 408 - 409). BRITISH MED JOURNAL PUBL GROUP

D

Dabrowski, M; Aerts, S; Van Hummelen, P; Craessaerts, K; De Moor, B; Annaert, W; Moreau, Y; (2003) Gene profiling of hippocampal neuronal culture. J Neurochem , 85 (5) pp. 1279-1288.

Davies, NA; Cochrane, G; Hanna, M; (2003) Muscle disorders. In: Greenwood, RJ and Barnes, MP and McMillan, TM and Ward, CD, (eds.) Handbook of neurological rehabilitation. (pp. 705-725). Psychology Press: Hove.

Davies, NP; Hanna, MG; (2003) The skeletal muscle channelopathies: distinct entities and overlapping syndromes. CURR OPIN NEUROL , 16 (5) 559 - 568. 10.1097/01.wco.0000093098.34793.09.

De Strooper, B; (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron , 38 (1) pp. 9-12.

De Strooper, B; Woodgett, J; (2003) Alzheimer's disease: Mental plaque removal. Nature , 423 (6938) pp. 392-393. 10.1038/423392a.

Doder, M; Rabiner, EA; Turjanski, N; Lees, AJ; Brooks, DJ; 11C-WAY 100635 PET study, ; (2003) Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study. Neurology , 60 (4) pp. 601-605.

de Silva, R; Hope, A; Pittman, A; Weale, ME; Morris, HR; Wood, NW; Lees, AJ; (2003) Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy. NEUROLOGY , 61 (3) 407 - 409.

de Silva, R; Lashley, T; Gibb, G; Hanger, D; Hope, A; Reid, A; Bandopadhyay, R; (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. NEUROPATH APPL NEURO , 29 (3) 288 - 302.

de Silva, R.; Lashley, T.; Gibb, G.; Hanger, D.; Hope, A.; Reid, A.; Bandopadhyay, R.; (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathology and Applied Neurobiology , 29 (3) pp. 288-302. 10.1046/j.1365-2990.2003.00463.x.

E

Edwards, M; Wood, N; Bhatia, K; (2003) Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature. MOVEMENT DISORD , 18 (6) 706 - 711. 10.1002/mds.10411.

Edwards, M; Wood, N; Bhatia, K; (2003) Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature. Movement Disorders , 18 (6) pp. 706-711.

Edwards, M.J.; Huang, Y.-Z.; Wood, N.W.; Rothwell, J.C.; Bhatia, K.P.; (2003) Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain , 126 (9) pp. 2074-2080. 10.1093/brain/awg209.

Edwards, MJ; Huang, YZ; Wood, NW; Rothwell, JC; Bhatia, KP; (2003) Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. BRAIN , 126 2074 - 2080. 10.1093/brain/awg209.

Eerola, J; Hernandez, D; Launes, J; Hellström, O; Hague, S; Gulick, C; Johnson, J; (2003) Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD. Neurology , 61 (7) pp. 1000-1002.

El-Agnaf, OM; Salem, SA; Paleologou, KE; Cooper, LJ; Fullwood, NJ; Gibson, MJ; Curran, MD; (2003) Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J , 17 (13) pp. 1945-1947. 10.1096/fj.03-0098fje.

Emre, M; Lees, AJ; (2003) Parkinsonism and dementia: Synucleinopathies, tauopathies and beyond - Introduction. MOVEMENT DISORDERS , 18 S1-S1. 10.1002/mds.10556.

F

Frank, RA; Galasko, D; Hampel, H; Hardy, J; de Leon, MJ; Mehta, PD; Rogers, J; (2003) Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging , 24 (4) pp. 521-536.

G

Gerschlager, W; Katzenschlager, R; Schrag, A; Lees, AJ; Brown, P; Quinn, N; Bhatia, KP; (2003) Quality of life in patients with orthostatic tremor. J NEUROL , 250 (2) 212 - 215. 10.1007/s00415-003-0980-9.

Gibson, GE; Kingsbury, AE; Xu, H; Lindsay, JG; Daniel, S; Foster, OJ; Lees, AJ; (2003) Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease. Neurochem Int , 43 (2) pp. 129-135.

Goldstein, D.B.; Ahmadi, K.R.; Weale, M.E.; Wood, N.W.; (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends in Genetics , 19 (11) pp. 615-622. 10.1016/j.tig.2003.09.006.

Goldstein, DB; Ahmadi, KR; Weale, ME; Wood, NW; (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. TRENDS GENET , 19 (11) 615 - 622. 10.1016/j.tig.2003.09.006.

Grover, A; England, E; Baker, M; Sahara, N; Adamson, J; Granger, B; Houlden, H; (2003) A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy. EXP NEUROL , 184 (1) 131 - 140. 10.1016/S0014-4886(03)00393-5.

Groves, MJ; Schanzer, A; Simpson, AJ; An, SF; Kuo, LT; Scaravilli, F; (2003) Profile of adult rat sensory neuron loss, apoptosis and replacement after sciatic nerve crush. J NEUROCYTOL , 32 (2) 113 - 122.

H

Hadjivassiliou, M; Grunewald, R; Sharrack, B; Sanders, D; Lobo, A; Williamson, C; Woodroofe, N; (2003) Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. BRAIN , 126 685 - 691. 10.1093/brain/awg050.

Hague, S; Rogaeva, E; Hernandez, D; Gulick, C; Singleton, A; Hanson, M; Johnson, J; (2003) Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol , 54 (2) pp. 271-274. 10.1002/ana.10663.

Hardy, J; (2003) Alzheimer's disease: genetic evidence points to a single pathogenesis. Ann Neurol , 54 (2) pp. 143-144. 10.1002/ana.10624.

Hardy, J; (2003) Impact of genetic analysis on Parkinson's disease research. In: MOVEMENT DISORDERS. (pp. S96 - S98). WILEY-LISS

Hardy, J; (2003) The relationship between Lewy body disease, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences , 991 pp. 167-170.

Hardy, J; (2003) The relationship between amyloid and tau. J Mol Neurosci , 20 (2) pp. 203-206. 10.1385/JMN:20:2:203.

Hardy, J; Cookson, MR; Singleton, A; (2003) Genes and parkinsonism. Lancet Neurol , 2 (4) pp. 221-228.

Hardy, J; Singleton, A; Gwinn-Hardy, K; (2003) Ethnic differences and disease phenotypes. Science , 300 (5620) pp. 739-740. 10.1126/science.300.5620.739.

Hargreaves, IP; Heales, SJR; Briddon, A; Lee, PJ; Hanna, MG; Land, JM; (2003) Primary pyruvate dehydrogenase E3 binding protein deficiency with mild hyperlactataemia and hyperalaninaemia. J INHERIT METAB DIS , 26 (5) 505 - 506.

Harold, D; Peirce, T; Moskvina, V; Myers, A; Jones, S; Hollingworth, P; Moore, P; (2003) Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Hum Genet , 113 (3) pp. 258-267. 10.1007/s00439-003-0960-2.

Hernandez, D; Hanson, M; Singleton, A; Gwinn-Hardy, K; Freeman, J; Ravina, B; Doheny, D; (2003) Mutation at the SCA17 locus is not a common cause of parkinsonism. Parkinsonism Relat Disord , 9 (6) pp. 317-320.

Herreman, A; Van Gassen, G; Bentahir, M; Nyabi, O; Craessaerts, K; Mueller, U; Annaert, W; (2003) γ-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. Journal of Cell Science , 116 (6) pp. 1127-1136. 10.1242/jcs.00292.

Herreman, A; Van Gassen, G; Bentahir, M; Nyabi, O; Craessaerts, K; Mueller, U; Annaert, W; (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci , 116 (Pt 6) pp. 1127-1136.

Hogg, M; Grujic, ZM; Baker, M; Demirci, S; Guillozet, AL; Sweet, AP; Herzog, LL; (2003) The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. ACTA NEUROPATHOL , 106 (4) 323 - 336. 10.1007/s00401-003-0734-x.

Holton, JL; Beesley, C; Winchester, B; Al-Memar, A; (2003) Vacuolar myopathy in twin girls. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 29 (5) 525 - 525.

Hope, AD; de Silva, R; Fischer, DF; Hol, EM; van Leeuwen, FW; Lees, AJ; (2003) Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J NEUROCHEM , 86 (2) 394 - 404. 10.1046/j.1471-4159.2003.01844.x.

Houlden, H; Lincoln, S; Farrer, M; Cleland, PG; Hardy, J; Orrell, RW; (2003) Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. NEUROLOGY , 61 (10) 1423 - 1426.

Houlden, H.; Lincoln, S.; Farrer, M.; Cleland, P.G.; Hardy, J.; Orrell, R.W.; (2003) Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. Neurology , 61 (10) pp. 1423-1426.

I

Iseki, E; Togo, T; Suzuki, K; Katsuse, O; Marui, W; de Silva, R; Lees, A; (2003) Dementia with Lewy bodies from the perspective of tauopathy. ACTA NEUROPATHOL , 105 (3) 265 - 270. 10.1007/s00401-002-0644-3.

J

Janssen, JC; Beck, JA; Campbell, TA; Dickinson, A; Fox, NC; Harvey, RJ; Houlden, H; (2003) Early onset familial Alzheimer's disease - Mutation frequency in 31 families. NEUROLOGY , 60 (2) 235 - 239.

Johansson, A; Hampel, H; Faltraco, F; Buerger, K; Minthon, L; Bogdanovic, N; Sjögren, M; (2003) Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci Lett , 340 (1) pp. 69-73.

Josephs, K.A.; Holton, J.L.; Rossor, M.N.; Braendgaard, H.; Ozawa, T.; Fox, N.C.; Petersen, R.C.; (2003) Neurofilament inclusion body disease: a new proteinopathy? Brain , 126 (10) pp. 2291-2303. 10.1093/brain/awg231.

Josephs, KA; Holton, JL; Rossor, MN; Braendgaard, H; Ozawa, T; Fox, NC; Petersen, RC; (2003) Neurofilament inclusion body disease. In: ANNALS OF NEUROLOGY. (pp. S51 - S51). WILEY-LISS

Josephs, KA; Holton, JL; Rossor, MN; Braendgaard, H; Ozawa, T; Fox, NC; Petersen, RC; (2003) Neurofilament inclusion body disease: a new proteinopathy? BRAIN , 126 2291 - 2303. 10.1093/brain/awg231.

Josephs, KA; Holton, JL; Rossor, MN; Braendgaard, H; Petersen, RC; Pearl, GS; Ganguly, M; (2003) Neurofilament inclusion body disease: a new proteinopathy. NEUROPATH APPL NEURO , 29 (5) 521 - 521.

K

Kahle, PJ; De Strooper, B; (2003) Attack on amyloid. EMBO Rep , 4 (8) pp. 747-751. 10.1038/sj.embor.embor905.

Katsuse, O; Iseki, E; Arai, T; Akiyama, H; Togo, T; Uchikado, H; Kato, M; (2003) 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. ACTA NEUROPATHOL , 106 (3) 251 - 260. 10.1007/s00401-003-0728-8.

Katzenschlager, R; Cardozo, A; Cobo, MRA; Tolosa, E; Lees, AJ; (2003) Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. MOVEMENT DISORD , 18 (10) 1123 - 1131. 10.1002/mds.10523.

Katzenschlager, R; Costa, D; Gerschlager, W; O'Sullivan, J; Zijlmans, J; Gacinovic, S; Pirker, W; (2003) [I-123]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. ANN NEUROL , 53 (4) 489 - 496. 10.1002/ana.10475.

Katzenschlager, R; Costa, D; Gerschlager, W; O'Sullivan, J; Zijlmans, J; Gacinovic, S; Pirker, W; (2003) [I-12]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. (vol 53, pg 489, 2003). ANNALS OF NEUROLOGY , 54 (2) 278 - 278.

Katzenschlager, R; Sampaio, C; Costa, J; Lees, A; (2003) Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2) CD003735-. 10.1002/14651858.CD003735.

Khan, N.L.; Graham, E.; Critchley, P.; Schrag, A.E.; Wood, N.W.; Lees, A.J.; Bhatia, K.P.; (2003) Parkin disease: a phenotypic study of a large case series. Brain , 126 (6) pp. 1279-1292. 10.1093/brain/awg142.

Khan, NL; Graham, E; Critchley, P; Schrag, AE; Wood, NW; Lees, AJ; Bhatia, KP; (2003) Parkin disease: a phenotypic study of a large case series. BRAIN , 126 1279 - 1292. 10.1093/brain/awg142.

Khan, NL; Wood, NW; Bhatia, KP; (2003) Autosomal recessive, DYT2-like primary torsion dystonia - A new family. NEUROLOGY , 61 (12) 1801 - 1803.

Kuo, L; Scaravilli, F; Groves, MJ; An, SF; (2003) Gene expression of neurotrophins and their receptors in the dorsal root ganglion after axotomy and systemic NT-3 treatment. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 578 - 578). AMER ASSN NEUROPATHOLOGISTS INC

Kuoppamaki, M; Giunti, P; Quinn, N; Wood, NW; Bhatia, KP; (2003) Slowly progressive cerebellar ataxia and cervical dystonia: Clinical presentation of a new form of spinocerebellar ataxia? MOVEMENT DISORD , 18 (2) 200 - 206. 10.1002/mds.10308.

L

Lang, AE; Lees, AJ; (2003) Untitled. MOVEMENT DISORDERS , 18 (1) 1 - 1. 10.1002/mds.10410.

Lauwers, E; Debyser, Z; Van Dorpe, J; De Strooper, B; Nuttin, B; Baekelandt, V; (2003) Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol , 13 (3) pp. 364-372.

Lawrence, AD; Evans, AH; Lees, AJ; (2003) Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? LANCET NEUROL , 2 (10) 595 - 604.

Lee, M.-J.; Stephenson, D.A.; Groves, M.J.; Sweeney, M.G.; Davis, M.B.; An, S.-F.; Houlden, H.; (2003) Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4 ) gene. Human Molecular Genetics , 12 (15) pp. 1917-1925. 10.1093/hmg/ddg198.

Lee, MJ; Stephenson, DA; Groves, MJ; Sweeney, MG; Davis, MB; An, SF; Houlden, H; (2003) Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4) gene. HUM MOL GENET , 12 (15) 1917 - 1925. 10.1093/hmg/ddg198.

Lees, AJ; (2003) Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. In: MOVEMENT DISORDERS. (pp. S28 - S33). WILEY-LISS

Lees, AJ; (2003) Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. Mov Disord , 18 Sup S28-S33. 10.1002/mds.10560.

Lees, AJ; Grosset, DG; (2003) Dopamine transporter imaging. Movement Disorders , 18 (Suppl.) S1-S2.

Lees, AJ; Grosset, DG; (2003) Dopamine transporter imaging. Mov Disord , 18 Sup S1-S2. 10.1002/mds.10570.

Leigh, PN; Ludolph, AC; Payan, CAM; Graf, M; Lacomblez, L; Vidailhet, M; Landwehrmeyer, B; (2003) Cross-sectional clinical description of a large prospective cohort of patients with progressive supranuclear palsy or multiple system atrophy: The NNIPPS project. In: ANNALS OF NEUROLOGY. (pp. S70 - S71).

Lhatoo, SD; Perunovic, B; Love, S; Houlden, H; Campbell, MJ; (2003) Familial idiopathic brain calcification - A new and familial alpha-synucleinopathy? EUR NEUROL , 49 (4) 223 - 226. 10.1159/000070189.

Lichtenthaler, SF; Dominguez, DI; Westmeyer, GG; Reiss, K; Haass, C; Saftig, P; De Strooper, B; (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem , 278 (49) pp. 48713-48719. 10.1074/jbc.M303861200.

Lincoln, S; Wiley, J; Lynch, T; Langston, JW; Chen, R; Lang, A; Rogaeva, E; (2003) Parkin-proven disease: common founders but divergent phenotypes. Neurology , 60 (10) pp. 1605-1610.

Lincoln, SJ; Maraganore, DM; Lesnick, TG; Bounds, R; de Andrade, M; Bower, JH; Hardy, JA; (2003) Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord , 18 (11) pp. 1306-1311. 10.1002/mds.10601.

Liolitsa, D; Rahman, S; Benton, S; Carr, LJ; Hanna, MG; (2003) Is the mitochondrial complex IND5 gene a hot-spot for MELAS causing mutations? ANN NEUROL , 53 (1) 128 - 132. 10.1002/ana.10435.

Lohmann, E; Periquet, M; Bonifati, V; Wood, NW; De Michele, G; Bonnet, AM; Fraix, V; (2003) How much phenotypic variation can be attributed to parkin genotype? ANN NEUROL , 54 (2) 176 - 185. 10.1002/ana.10613.

M

Maraganore, DM; Farrer, MJ; Lesnick, TG; de Andrade, M; Bower, JH; Hernandez, D; Hardy, JA; (2003) Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease. Mov Disord , 18 (11) pp. 1233-1239. 10.1002/mds.10547.

Maraganore, DM; de Andrade, M; Lesnick, TG; Farrer, MJ; Bower, JH; Hardy, JA; Rocca, WA; (2003) Complex interactions in Parkinson's disease: a two-phased approach. Mov Disord , 18 (6) pp. 631-636. 10.1002/mds.10431.

Marlow, L; Canet, RM; Haugabook, SJ; Hardy, JA; Lahiri, DK; Sambamurti, K; (2003) APH1, PEN2, and Nicastrin increase Abeta levels and gamma-secretase activity. Biochem Biophys Res Commun , 305 (3) pp. 502-509.

Miller, RF; Shahmanesh, M; Hanna, MG; Unwin, RJ; Schapira, AHV; Weller, IVD; (2003) Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors. ANTIVIR THER , 8 (3) 253 - 257.

Misbahuddin, A; Placzek, MR; Taanman, JW; Cooper, JM; Warner, TT; (2003) Study of mutant and wild type torsin A in human SH-SY5Y cell lines. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 409 - 409). BRITISH MED JOURNAL PUBL GROUP

Moreau, Y; Aerts, S; De Moor, B; De Strooper, B; Dabrowski, M; (2003) Comparison and meta-analysis of microarray data: from the bench to the computer desk. Trends Genet , 19 (10) pp. 570-577.

Morris, CM; O'Brien, KK; Gibson, AM; Hardy, JA; Singleton, AB; (2003) Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease. Neurosci Lett , 352 (2) pp. 151-153.

Morris, HR; Osaki, Y; Holton, J; Lees, AJ; Wood, NW; Revesz, T; Quinn, N; (2003) Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. NEUROLOGY , 61 (1) 102 - 104.

Mundy, HR; Jones, SJ; Hobart, JC; Hanna, MG; Lee, PJ; (2003) A randomized controlled study of modified cobratoxin in adrenomyeloneuropathy. NEUROLOGY , 61 (4) 528 - 530.

Murakami, D; Okamoto, I; Nagano, O; Kawano, Y; Tomita, T; Iwatsubo, T; De Strooper, B; (2003) Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene , 22 (10) pp. 1511-1516. 10.1038/sj.onc.1206298.

N

Nath, U; Ben-Shlomo, Y; Thomson, RG; Lees, AJ; Burn, DJ; (2003) Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology , 60 (6) pp. 910-916.

Nyabi, O; Bentahir, M; Horré, K; Herreman, A; Gottardi-Littell, N; Van Broeckhoven, C; Merchiers, P; (2003) Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem , 278 (44) pp. 43430-43436. 10.1074/jbc.M306957200.

P

Payami, H; Nutt, J; Gancher, S; Bird, T; McNeal, MG; Seltzer, WK; Hussey, J; (2003) SCA2 may present as levodopa-responsive parkinsonism. Mov Disord , 18 (4) pp. 425-429. 10.1002/mds.10375.

Periquet, M; Latouche, M; Lohmann, E; Rawal, N; De Michele, G; Ricard, S; Teive, H; (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. BRAIN , 126 1271 - 1278. 10.1093/brain/awg136.

Perry, EK; Kilford, L; Lees, AJ; Burn, DJ; Perry, RH; (2003) Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. ANN NEUROL , 54 (2) 235 - 238. 10.1002/ana.10639.

Pickford, F; Onstead, L; Camacho-Prihar, C; Hardy, J; McGowan, E; (2003) Expression of mBRI2 in mice. Neurosci Lett , 338 (2) pp. 95-98.

Pitt, M; Houlden, H; Jacobs, J; Mok, Q; Harding, B; Reilly, M; Surtees, R; (2003) Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. BRAIN , 126 2682 - 2692. 10.1093/brain/awg278.

Pitt, M.; Houlden, H.; Jacobs, J.; Mok, Q.; Harding, B.; Reilly, M.; Surtees, R.; (2003) Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain , 126 (12) pp. 2682-2692. 10.1093/brain/awg278.

Plun-Favreau, H; Perret, D; Diveu, C; Froger, J; Chevalier, S; Lelievre, E; Gascan, H; (2003) Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. J BIOL CHEM , 278 (29) 27169 - 27179. 10.1074/jbc.M303168200. Gold open access

Prime, KP; Edwards, SG; Pakianathan, MR; Holton, JL; Scaravilli, F; Miller, RF; (2003) Polymyositis masquerading as mitochondrial toxicity. SEX TRANSM INFECT , 79 (5) 417 - 418.

Proukakis, C; Auer-Grumbach, M; Wagner, K; Wilkinson, PA; Reid, E; Patton, MA; Warner, TT; (2003) Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene. Hum Mutat , 21 (2) 170-. 10.1002/humu.9108.

Proukakis, C; Crosby, AH; Auer-Grumbach, M; Wagner, K; Reid, E; Patton, MA; Warner, TT; (2003) Screening of the spastin gene in autosomal dominant hereditary spastic paraplegia reveals seven novel mutations. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 406 - 407). BRITISH MED JOURNAL PUBL GROUP

Pulkes, T; Liolitsa, D; Nelson, IP; Hanna, MG; (2003) Classical mitochondrial phenotypes without mtDNA mutations - The possible role of nuclear genes. NEUROLOGY , 61 (8) 1144 - 1147.

R

Revesz, T; Ghiso, J; Holton, JL; Frangione, B; (2003) Hereditary amyloidoses with neurodegeneration: familial British dementia and familial Danish dementia. In: Dickson, DW, (ed.) Neurodegeneration: the molecular pathology of dementia and movement disorders. (pp. 380-385). ISN Neuropath Press: Basel.

Revesz, T; Ghiso, J; Lashley, T; Plant, G; Rostagno, A; Frangione, B; Holton, JL; (2003) Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J NEUROPATH EXP NEUR , 62 (9) 885 - 898.

Revesz, T; Holton, JL; (2003) Anatamopathological spectrum of tauopathies. MOVEMENT DISORDERS , 18 S13 - S20. 10.1002/mds.10558.

Rippon, GA; Crook, R; Baker, M; Halvorsen, E; Chin, S; Hutton, M; Houlden, H; (2003) Presenilin 1 mutation in an African American family presenting with atypical Alzheimer dementia. ARCH NEUROL-CHICAGO , 60 (6) 884 - 888.

S

Scaravilli, F; Lucas, S; Gray, F; Kuo, L; Hall-Craggs, MA; An, SF; Miller, R; (2003) The changing presentation of encephalitis in AIDs. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 562 - 562). AMER ASSN NEUROPATHOLOGISTS INC

Schott, JM; Paviour, DC; Fox, NC; Stevens, JM; Lees, AJ; Rossor, MN; (2003) Picturing the atrophy patterns of progressive supranuclear palsy and multiple system atrophy in vivo using fluid registered MRI. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 410 - 410). BRITISH MED JOURNAL PUBL GROUP

Schrag, A; Selai, C; Davis, J; Lees, AJ; Jahanshahi, M; Quinn, N; (2003) Health-related quality of life in patients with progressive supranuclear palsy. MOVEMENT DISORD , 18 (12) 1464 - 1469. 10.1002/mds.10583.

Schroeter, EH; Ilagan, MX; Brunkan, AL; Hecimovic, S; Li, YM; Xu, M; Lewis, HD; (2003) A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci U S A , 100 (22) pp. 13075-13080. 10.1073/pnas.1735338100.

Schulz, JG; Annaert, W; Vandekerckhove, J; Zimmermann, P; De Strooper, B; David, G; (2003) Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling. J Biol Chem , 278 (49) pp. 48651-48657. 10.1074/jbc.M308424200.

Schulze, TG; Hardy, J; McMahon, FJ; (2003) Inconsistent designs of association studies: a missed opportunity. Mol Psychiatry , 8 (9) pp. 770-772. 10.1038/sj.mp.4001329.

Seemungal, BM; Faldon, M; Revesz, T; Lees, AJ; Zee, DS; Bronstein, AM; (2003) Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy. MOVEMENT DISORD , 18 (7) 818 - 822. 10.1002/mds.10434.

Sibbing, D; Trender-Gerhardt, I; Wood, NW; Oertel, WH; Bhatia, KP; Bandmann, O; (2003) The promoter region of the Menkes gene ATP7A is not altered in focal or generalized dystonia. ANN NEUROL , 53 (2) 278 - 279. 10.1002/ana.10436.

Siddiqui, A; Kerb, R; Weale, ME; Brinkmann, U; Smith, A; Goldstein, DB; Wood, NW; (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. NEW ENGL J MED , 348 (15) 1442 - 1448.

Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; Hulihan, M; (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science , 302 (5646) 841-. 10.1126/science.1090278.

Sorajja, P; Sweeney, MG; Chalmers, R; Sachdev, B; Syrris, P; Hanna, M; Wood, ND; (2003) Cardiac abnormalities in patients with Leber's hereditary optic neuropathy. HEART , 89 (7) 791 - 792.

Sultan, R; Hanna, MG; Rahman, S; Isenberg, DA; (2003) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Journal of Rheumatology , 43 (1) pp. 49-54.

Swinn, L; Schrag, A; Viswanathan, R; Bloem, BR; Lees, A; Quinn, N; (2003) Sweating dysfunction in Parkinson's disease. MOVEMENT DISORD , 18 (12) 1459 - 1463. 10.1002/mds.10586.

T

Tabrizi, SJ; Blamire, AM; Manners, DN; Rajagopalan, B; Styles, P; Schapira, AHV; Warner, TT; (2003) Creatine therapy for Huntington's disease: Clinical and MRS findings in a 1-year pilot study. NEUROLOGY , 61 (1) 141 - 142.

Tan, LC; Tanner, CM; Chen, R; Chan, P; Farrer, M; Hardy, J; Langston, JW; (2003) Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation. Mov Disord , 18 (7) pp. 758-763. 10.1002/mds.10432.

U

Ule, J; Jensen, KB; Ruggiu, M; Mele, A; Ule, A; Darnell, RB; (2003) CLIP identifies Nova-regulated RNA networks in the brain. Science , 302 (5648) pp. 1212-1215. 10.1126/science.1090095.

V

Valente, EM; Misbahuddin, A; Brancati, F; Placzek, MR; Garavaglia, B; Salvi, S; Nemeth, A; (2003) Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: Evidence for genetic heterogeneity. MOVEMENT DISORD , 18 (9) 1047 - 1051. 10.1002/mds.10476.

W

Warner, TT; Schapira, AHV; (2003) Genetic and environmental factors in the cause of Parkinson's disease. ANN NEUROL , 53 S16 - S23. 10.1002/ana.10487.

Weale, ME; Depondt, C; Macdonald, SJ; Smith, A; Lai, PS; Shorvon, SD; Wood, NW; (2003) Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: Implications for linkage-disequilibrium gene mapping. AM J HUM GENET , 73 (3) 551 - 565.

Weeks, R; Scaravilli, F; Lees, A; Carroll, C; Husain, M; Rudge, P; (2003) Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome. Movement Disorders , 18 (3) pp.331-336.

Weeks, RA; Scaravilli, F; Lees, AJ; Carroll, C; Husain, M; Rudge, P; (2003) Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome. MOVEMENT DISORD , 18 (3) 331 - 336. 10.1002/mds.10347.

Wilkinson, P.A.; Crosby, A.H.; Turner, C.; Patel, H.; Wood, N.W.; Schapira, A.H.; Warner, T.T.; (2003) A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. Neurology , 61 (2) pp. 235-238.

Wilkinson, PA; Crosby, AH; Turner, C; Patel, H; Wood, NW; Schapira, AH; Warner, TT; (2003) A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. NEUROLOGY , 61 (2) 235 - 238.

Wilkinson, PA; Hart, PE; Patel, H; Warner, TT; Crosby, AH; (2003) SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J NEUROL SCI , 216 (1) 43 - 45. 10.1016/S0022-510X(03)00210-7.

Wood, N; (2003) Principles of genetic counselling. In: EPILEPSIA. (pp. 9 - 9). BLACKWELL PUBLISHING INC

Wood, NW; (2003) Neurogenetics. In: Fowler, TJ and Scadding, JW, (eds.) Clinical neurology. (pp. 119-129). Arnold: London.

Worth, PF; Wood, NW; (2003) A systematic and structured approach to the investigation of ataxia. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1166 - 1166). BRITISH MED JOURNAL PUBL GROUP

Z

Zetterberg, H; Nexö, E; Regland, B; Minthon, L; Boson, R; Palmér, M; Rymo, L; (2003) The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease. Clin Chem , 49 (7) pp. 1195-1198.

Zetterberg, H; Palmér, M; Boreström, C; Rymo, L; Blennow, K; (2003) The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C. Blood , 101 (9) pp. 3749-3750. 10.1182/blood-2003-01-0084.

Zetterberg, H; Palmér, M; Boreström, C; Rymo, L; Blennow, K; Miller, JW; Green, R; (2003) The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C [2] (multiple letters). Blood , 101 (9) pp. 3749-3751. 10.1182/blood-2003-01-0135.

Zetterberg, H; Rymo, L; Coppola, A; D'Angelo, A; Spandidos, DA; Blennow, K; (2003) Erratum: MHTFR C677T and A1298C polymorphisms and mutated sequences occuring in cis (European Journal of Human Genetics (2002) vol. 10 (579-582)). European Journal of Human Genetics , 11 (1) 106-. 10.1038/sj.ejhg.5200931.

Zetterberg, H; Wahlund, LO; Blennow, K; (2003) Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett , 352 (1) pp. 67-69.

Zetterberg, H; Zafiropoulos, A; Spandidos, DA; Rymo, L; Blennow, K; (2003) Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion. Hum Reprod , 18 (9) pp. 1948-1950.

This list was generated on Sun May 22 03:26:51 2016 BST.